# G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)

> **NCT00255645** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 4500 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00255645
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 4500 (—)
- **Why stopped:** The development program has been terminated
- **Last updated:** 2008-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255645, "G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00255645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*